Yang, Lishou published the artcileSynthesis of novel 1-phenyl-benzopyrrolizidin-3-one derivatives and evaluation of their cytoneuroprotective effects against NMDA-induced injury in PC12 cells, HPLC of Formula: 103-26-4, the publication is Bioorganic & Medicinal Chemistry (2022), 116675, database is CAplus and MEDLINE.
A range of novel 1-phenyl-benzopyrrolizidin-3-one derivatives I (R1 = Ph, 2-MeOC6H4, 3-BnOC6H4, etc.; R2 = H, 8-F, 7-OBn) were synthesized and evaluated for neuroprotective effects against N-methyl-D-aspartate (NMDA)-induced injury in PC12 cells. Interestingly, derivatives that 1-Ph moiety bearing electron-donating group, especially benzyloxy, and the trans-forms exhibited better protective activity against NMDA-induced neurotoxicity. Compound I (R1 = 3-BnOC6H4; R2 = 8-F) demonstrated the best neuroprotective potency and shown a dose-dependent prevention. The increased intracellular calcium (Ca2+) influx caused by NMDA in PC12 cells was reversed in the case of compound I (R1 = 3-BnOC6H4; R2 = 8-F) pretreatment at 15μM. These results suggested that the synthesized 1-phenyl-benzopyrrolizidin-3-one derivatives exerted neuroprotective effect on NMDA-induced excitotoxicity in PC12 cells associated with inhibition of Ca2+ overload and can be further optimized for the development of neuroprotective agents.
Bioorganic & Medicinal Chemistry published new progress about 103-26-4. 103-26-4 belongs to esters-buliding-blocks, auxiliary class Alkenyl,Benzene,Ester,Protease,Tyrosinase,Natural product, name is Methyl 3-phenyl-2-propenoate, and the molecular formula is C4H6O3, HPLC of Formula: 103-26-4.
Referemce:
https://en.wikipedia.org/wiki/Ester,
Ester – an overview | ScienceDirect Topics